Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Targeting Upper Motor Neurons to Treat ALS
Disease Discoveries

Targeting Upper Motor Neurons to Treat ALS

By Nora DunneJan 22, 2016
Share
Facebook Twitter Email

Selective Gene Delivery Modifies Diseased Cells

The study showed that upper motor neurons (green) can be transduced without affecting other cells in the motor cortex, an important achievement for future translational efforts.
The study showed that upper motor neurons (green) can be transduced without affecting other cells in the motor cortex, an important achievement for future translational efforts.

Scientists have demonstrated for the first time that it is possible to specifically modify gene expression in diseased upper motor neurons, brain cells that break down in ALS.

The new Northwestern Medicine study, published in Nature Gene Therapy, provides evidence that lays a foundation for developing future gene replacement therapies to treat patients with the fatal neuromuscular disorder.

Using a nontoxic virus injected directly into the motor cortex of mouse models with ALS, the scientists showed they can deliver new genes to damaged upper motor neurons. This process of transferring DNA from a virus to neurons is called transduction.

To test the feasibility of transduction, the research team had the virus deliver a gene that expresses a green fluorescent protein – the color helped the scientists visualize how the neurons worked. Now that they know the transduction strategy is effective, they’ll use it in future research to deliver genes that correct mutations in ALS cells.

Importantly, the scientists were able to specifically modify the gene expression in diseased upper motor neurons without disturbing other neurons in the motor cortex. Inadvertently manipulating other cells could set off a cascade of unknown effects.

“The brain is very complex, with many different cells, but in ALS only a distinct neuron population shows initial vulnerability and undergoes progressive degeneration,” said lead study author Hande Ozdinler, PhD, assistant professor of Neurology. “To develop effective treatment strategies, we must deliver genes only to the neurons in need. This is not easy to accomplish – previous studies have managed to induce a broad but non-specific transduction of many different neurons.”

ALS, or amyotrophic lateral sclerosis, is marked by the deterioration of motor neurons, which causes muscle weakness and impaired speaking, swallowing and breathing, eventually leading to paralysis and death. In previous research, Ozdinler showed that defects in upper motor neurons (also known as corticospinal motor neurons), which send messages from the brain to the spinal cord to activate voluntary movement, may be a starting point for the disease.

Hande-Ozdinler-Feinberg-250
Hande Ozdinler, PhD, assistant professor of Neurology, led the studies.

In the recent study, Ozdinler’s team tested seven different strains of the adeno-associated virus. They found that a nontoxic strain called AAV2-2, already used in clinical studies for diseases such as Parkinson’s, was able to deliver genes to damaged upper motor neurons at rates higher than ever seen before.

“With just a one-time injection into the motor cortex, genes were very specifically delivered to the upper motor neurons,” Ozdinler said. “Among all cells transduced, about 70 percent were upper motor neurons. Without selectivity, this would be about 1 percent.”

The investigators showed that the AAV2-2 virus transduced upper motor neurons in models of both pre-symptomatic and symptomatic stages of ALS, suggesting patients could eventually benefit from therapy based on this work even after they’ve started experiencing symptoms.

“This new study has very important clinical implications, especially for patients with familial ALS who display upper motor neuron defects,” Ozdinler said.

An upper motor neuron projects information to the spinal cord through its axon, a long, branch-like part of the cell that sends impulses to other cells. The fluorescent protein that was transferred to the neurons made this process visible.

“We saw that during ALS, damaged upper motor neurons stop talking to spinal neurons,” Ozdinler said. “In further research, we will examine how we can modulate gene expression to introduce correct versions of mutated genes and improve that connectivity and motor functions.”

Others authors of the study include Javier Jara, PhD, research assistant professor of Neurology, Macdonell Stanford, Yongling Zhu, PhD, assistant professor of Ophthalmology, Michael Tu, William Hauswirth, PhD, Martha Bohn, PhD, professor emeritus of Pediatrics, and Steven DeVries, MD, PhD, professor of Ophthalmology and Physiology.

The research was funded by the Les Turner ALS Foundation, Herbert C Wenske Foundation, Northwestern University Clinical and Translational Sciences (NUCATS) Institute, an ALSA Safenowitz fellowship and the Weinberg College of Arts and Sciences at Northwestern University.

In the absence of alsin function, upper motor neurons display many cellular defects, including defects in their mitochondria and Golgi apparatus and disintegration of apical dendrites.
In the absence of alsin function, upper motor neurons display many cellular defects, including defects in their mitochondria and Golgi apparatus and disintegration of apical dendrites.

Shedding Light on Cellular Degeneration in Juvenile ALS

In a second recent paper, published in Human Molecular Genetics, Ozdinler revealed novel upper motor neuron defects in a model of the most severe form of juvenile ALS.

Using a fluorescent reporter line developed by Ozdinler’s lab in 2013, the research team genetically labeled the upper motor neurons in mice without the ALS2 gene, which is mutated in cases of early-onset ALS.

The study showed that vulnerable upper motor neurons display defects in their mitochondria and Golgi apparatus, important functional parts of the cells.

“Revealing novel cellular defects in upper motor neurons is important to develop new drug targets for ALS,” Ozdinler said. “Previously we did not know why ALS patients with the alsin mutation develop the disease so early. Our studies reveal that upper motor neurons displayed defects in their mitochondria, Golgi apparatus and failed to maintain their cellular integrity. This broad spectrum of neuronal dysfunction could indeed cause an early and profound phenotype.”

Mukesh Gautam, PhD, Marco Martina, MD, PhD, associate professor of Physiology, Javier Jara, PhD, and Gabriella Sekerka, MVDr, CSc, ’01 GME, research assistant professor of Physiology, were additional authors of the paper. Han-Xiang Deng, MD, PhD, research professor of Neurology, and Teepu Siddique, MD, professor of Neurology, shared the mouse model that enabled this work. The research was funded by National Institutes of Health grant R21-NS085750-01 and the Les Turner ALS Foundation.

Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Comments are closed.

Latest News

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

AOA Honors New Members

Mar 20, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230315_NM036
20230315_NM046
20230315_NM134
20230315_NM205
20230315_NM206
20230315_NM132
20230315_NM130
20230315_NM082
20230315_NM063
20230315_NM058
20230315_NM030
20230315_NM038

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.